Feb 24, 2025 | Press Releases
Handley Joins as President of Tivic Biopharma and Chief Operating Officer of Tivic Health Following Its Licensing of Strategic Biopharma Assets From Statera Biopharma FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics...
Feb 12, 2025 | Press Releases
Broad licensing agreement accelerates Tivic’s transformation into a diversified therapeutics company, adds late-stage immunotherapeutic to clinical pipeline. Potential for FDA approval within 24 months. FREMONT, Calif. – Tivic Health Systems, Inc.,...
Dec 23, 2024 | Press Releases
Provides updates on vagus nerve stimulation (VNS) program and expectations for 2025 FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO...
Nov 14, 2024 | Press Releases
Pre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months...
Nov 14, 2024 | Press Releases
FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization study for Tivic Health’s patent...
Nov 12, 2024 | Press Releases
Patents cover methods used to identify key treatment points and dynamically personalize simulation FREMONT, Calif. – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced...